共 79 条
[1]
Hofbauer LC(2000)Clinical review 114: Hot Topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases J Clin Endocrinol Metab 85 2355-2363
[2]
Heufelder AE(1998)Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone Biochem Biophys Res Commun 246 337-341
[3]
Tsukii K(2008)Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004 Am J Clin Nutr 88 1519-1527
[4]
Shima N(1979)Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium Clin Sci (Lond) 56 157-161
[5]
Mochizuki S(1999)Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel J Am Geriatr Soc 47 1195-1201
[6]
Looker AC(2010)Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force Ann Intern Med 153 815-825
[7]
Pfeiffer CM(2008)Vitamin D insufficiency: disease or no disease? J Bone Miner Res 23 1052-1060
[8]
Lacher DA(2003)Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D J Am Coll Nutr 22 142-146
[9]
Sorensen OH(1998)Redefining vitamin D insufficiency Lancet 351 805-806
[10]
Lund B(2004)Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults Am J Med 116 634-639